Yohance M Allette

Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance

Daniel M Harrison, Yohance M Allette, Yuxin Zeng, 2024, PloS one.

A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis.

Daniel M Harrison, Yohance M Allette, Shishir Dahal, 2023, Multiple sclerosis and related disorders.

Modulatory actions of HMGB1 on TLR4 and rage in the primary afferent sensory neuron

Y. M. Allette, Yohance M Allette, 2015 .

Identification of novel small molecule inhibitors of 4-diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) kinase of Gram-negative bacteria.

H. Vankayalapati, M. Tang, S. Odejinmi, 2011, Bioorganic & medicinal chemistry.

Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain

Sarah M. Wilson, R. Khanna, F. White, 2014, Brain, Behavior, and Immunity.

The HMGB1-RAGE axis mediates traumatic brain injury–induced pulmonary dysfunction in lung transplantation

G. Hutchins, G. Sandusky, H. Broxmeyer, 2014, Science Translational Medicine.

Suppression of pain‐related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine‐conjugated CRMP2 peptide

R. Khanna, F. White, Qi Li, 2013, Journal of neurochemistry.

The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction.

D. Wilkes, F. White, Y. M. Allette, 2015, Antioxidants & redox signaling.

Acrolein involvement in sensory and behavioral hypersensitivity following spinal cord injury in the rat

R. Shi, Jonghyuck Park, Lingxing Zheng, 2014, Journal of neurochemistry.